Eur Rev Med Pharmacol Sci 2021; 25 (4): 1788-1795

DOI: 10.26355/eurrev_202102_25072

Correlation analysis of serum placental growth factor, pregnancy-related plasma protein-A and disease severity in patients with hypertensive disorder in pregnancy

X.-W. Sun, X.-H. Li, C. Zhang, F.-Q. Meng, Y.-G. Xing, Y. Ding

Reproductive Medicine Centre, Affiliated Hospital of Weifang Medical College, Weifang, China. dlo5wi@163.com


OBJECTIVE: To analyze the correlation of serum placental growth factor (PLGF), pregnancy-associated plasma protein-A (PAPP-A) and disease severity in patients with hypertensive disorders in pregnancy (HDP).

PATIENTS AND METHODS: Altogether 88 pregnant women with hypertensive disorder who underwent prenatal examination and delivery in our hospital from March 2017 to February 2019 were selected and included as the research group (n=88), and 62 healthy pregnant women who underwent prenatal examination during the same period were included as the normal control group (n=62). Enzyme-linked immunosorbent assay (ELISA) was used to detect the expression levels of PAPP-A and PLGF in the serum of the two groups. The correlation of the expression levels of PAPP-A and PLGF with the severity of HDP was analyzed. The occurrence of adverse pregnancy outcomes in the two groups was compared, and the relationship of the expression levels of PAPP-A and PLGF with adverse pregnancy outcomes was compared.

RESULTS: PAPP-A expression level in serum of pregnant women in the research group was significantly higher than that in the control group, while PLGF expression level was significantly lower than that in the control group (p<0.001). PAPP-A expression level was positively correlated with HDF severity (r=0.753, p<0.001), while PLGF expression level was negatively correlated with HDP severity (r=-0.929, p<0.001). The incidence of adverse pregnancy outcomes in the research group was significantly higher than that in the control group (p<0.05). The serum PAPP-A level of patients in the group with adverse pregnancy outcomes was significantly higher than that in the group without adverse pregnancy outcomes, while PLGF level was significantly lower than that in the group without adverse pregnancy outcomes (p<0.001).

CONCLUSIONS: In conclusion, the expression levels of PAPP-A and PLGF in serum were closely related to the severity of HDP and could be used as indicators for disease monitoring.

Free PDF Download

To cite this article

X.-W. Sun, X.-H. Li, C. Zhang, F.-Q. Meng, Y.-G. Xing, Y. Ding
Correlation analysis of serum placental growth factor, pregnancy-related plasma protein-A and disease severity in patients with hypertensive disorder in pregnancy

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 4
Pages: 1788-1795
DOI: 10.26355/eurrev_202102_25072